AI and quick looks: could they speed up breast cancer screening?

NCT ID NCT05960188

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether radiologists can safely skip looking at detailed 3D breast scans when a quick 2D image or an AI score suggests the case is normal. Sixteen radiologists briefly viewed each case and rated how likely it was normal, then saw the AI's opinion. The goal is to see if this 'self-triage' could speed up screening without missing cancers. It's a very early step and not ready for real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI opinion (behavioral intervention)

What this could lead to

If successful, this could help radiologists work faster by safely skipping unnecessary 3D scans for clearly normal cases, potentially reducing screening time and cost.

What could go wrong

This is a very small, early study with only 16 radiologists. It does not test real-world outcomes, and the approach may not be safe or acceptable in practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Visual Attention Lab / Brigham and Women's Hospital

    Boston, Massachusetts, 02215, United States